Navigation Links
Common treatment to delay labor decreases preterm infants' risk for cerebral palsy
Date:8/28/2008

BIRMINGHAM, Ala. -- Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, M.D., and published in the Aug. 28 issue of The New England Journal of Medicine.

Cerebral palsy refers to a group of neurological disorders affecting control of movement and posture and limiting activity. The causes of cerebral palsy are not well understood, though cerebral palsy is attributed to brain injury or developmental abnormality during pregnancy, birth or in early childhood. It is estimated that cerebral palsy afflicts more than 200,000 Americans between the ages of 3 and 13, making it a leading cause of chronic childhood disability.

Magnesium sulfate is given routinely to prevent seizures in women with preeclampsia and to stop preterm labor. Previous research suggested that fetal exposure to magnesium sulfate before preterm birth might reduce the risk of cerebral palsy.

"The association between magnesium sulfate and a lower incidence of cerebral palsy has biologic plausibility, because magnesium stabilizes blood vessels, protects against damage from oxygen depletion, and protects against injury from swelling and inflammation, all of which threaten the vulnerable preterm brain," Rouse said. "Our study is the largest, most comprehensive effort to evaluate the effect of magnesium sulfate on the incidence of cerebral palsy in preterm infants."

Early preterm birth is a risk factor for cerebral palsy, and the magnitude of the risk rises the earlier a baby is born. During the past 20 to 30 years, the survival of infants born severely preterm has improved dramatically, and while some research suggests that the rate of cerebral palsy among the survivors of early preterm birth has decreased, other research suggests that it has not. Currently, approximately one of every three cases of cere
'/>"/>

Contact: Jennifer Lollar
jpark@uab.edu
205-934-3888
University of Alabama at Birmingham
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Why a common treatment for prostate cancer ultimately fails
2. Toxic chemicals found in common scented laundry products, air fresheners
3. Researchers identify cancer preventive properties in common vitamin supplement
4. Monash researcher receives prestigious Commonwealth Health Ministers award
5. Finding out what the Big Bang and ink jets have in common
6. A common aquatic animals genome can capture foreign DNA
7. Oregano oil works as well as synthetic insecticides to tackle common beetle pest
8. Cells lining milk ducts hold key to spread of common form of breast cancer
9. US Patent Office rejects companys claim for bean commonly grown by Latin American farmers
10. Early exposure to common weed killer impairs amphibian development
11. Largest ever study of genetics of common disease just got bigger

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...wire/ -- Global Rainmakers, Inc., an intellectual ...ratory, today announced that the company has exite...ommercialize its suite of technologies designed to...s. ,, During the past four years, the company h...d deploy a series of core--but expandable--technol...
(Date:11/4/2009)...re/ -- Glencoe Software, Inc., the commercial arm ...m ( http://openmicroscopy.org ), is proud to ann...of Cell Biology,s exciting new project titled "The...d a $2.5M stimulus grant through the National Inst...am, as part of the American Reinvestment and Recov...
(Date:11/3/2009)...timate loner of the ocean, cruising thousands of m... has discovered that the sharks have maintained su...s of thousands of years the white sharks in the no... into a population genetically distinct from shark...large, highly mobile species," said Salvador Jorge...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 1Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 2Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 3Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 5Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 6Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 7Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 8Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 9Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 1Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 2Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 3Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 4Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 5Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 6Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 7Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 8Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 9Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 10Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 11Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 12Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 1Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 2Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 3
...ulder, CO, USA The December Geosphere , The Geol...ne. Topics include detailed data integration from ..., sedimentology, and paleontology, to study the so...million years ago; sedimentation in a piggyback ba...ange, Nevada; and a study of the South Balkan exte...
...LUMBIA, Mo. In the race for bioengineered crops, ...t leg in a multi-leg relay. Once the sequence is c...s to identify genes, functions. A draft sequence o...plete genome will be available soon. Taking the ne...erdisciplinary Plant Group researchers have demons...
...ientists at St. Jude Children,s Research Hospital ... type is so ready to change its identity that it r...rox1 to dissuade it. , The researchers showed th... is sufficient to reprogram a specialized type of ...n the absence of active Prox1, the LEC actually lo...
Other Biology News:December Geosphere media highlights 2December Geosphere media highlights 3Tool helps identify gene function in soybeans 2Reprogrammable cell type depends on a single gene to keep its identity 2
(Date:11/6/2009)...UINCY, Mass., Nov. 6 Myriant Techn... developer and manufacturer of renewable bio-chem...ed technology provider Uhde GmbH, one of the world...), announced an alliance for the engineering, proc...ased Succinic Acid plants based on renewable feeds...
(Date:11/6/2009)...ALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics... or the "Company") today announced updated results...in patients with sarcomas metastatic to the lung i...ive Tissue Oncology Society Meeting held in Miami ...er presentation, entitled "A Phase II Study of Int...
(Date:11/5/2009)...AITHERSBURG, Md., Nov. 5 ... financial results for the third quarter ended Sep...6 million ($0.04 per share) for the three months e...$6.8 million ($0.08 per share) in the comparable q...r 30, 2009, GenVec,s net loss was $14.1 million ($...
(Date:11/5/2009)...ANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCal...ing supplier of innovative products for processing...lts for the first quarter of fiscal 2010. ,, Fo...y reported revenues of $5.2 million, a 15 percent ...t quarter a year ago. The Company said the key con...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...d DURHAM, N.C., Jan. 27 As farmers,look to get mo...onsanto,(NYSE: MON ) is exploring unique ways to...h the seed. Monsanto,s new collaboration with Gras...hat by expanding the benefits of,Monsanto,s resear..., Today, Monsanto announced that it has establ...
..., Canada, Jan. 27 InNexus Biotechnology Inc. (OTC...www.ixsbio.com ), announced today that it has comp... and conditions as the private placement that was ...ment, totaled $2,207,000 of 10% unsecured converti...e into common shares of InNexus at the rate of one...
...am of scientists at the U.S. Department of Energy,...ration with researchers from the University of Del...catalyst that could make ethanol-powered fuel cell... two crucial, and previously unreachable steps nee... fuel cell reactions. Their results are published ...
Other Biology Technology:New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 3New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 4InNexus Completes Previously Announced Private Placement 2New catalyst paves the path for ethanol-powered fuel cells 2
dNTP Set from Invitrogen
StrepMAB-Immo coated microplate; 96 well from IBA GmbH
cAMP[125I] Direct SPA Screening Biotrak Assay from GE Healthcare, formerly Amersham Biosciences
GIBCO Leibovitz's L-15 Medium powder from Invitrogen
Biology Products: